{"id":"https://openalex.org/W2587682809","doi":"https://doi.org/10.1080/17512433.2017.1292125","title":"GLP-1 receptor agonists in the treatment of polycystic ovary syndrome","display_name":"GLP-1 receptor agonists in the treatment of polycystic ovary syndrome","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-13","ids":{"openalex":"https://openalex.org/W2587682809","doi":"https://doi.org/10.1080/17512433.2017.1292125","mag":"2587682809","pmid":"https://pubmed.ncbi.nlm.nih.gov/28276778"},"language":"en","primary_location":{"id":"doi:10.1080/17512433.2017.1292125","doi":"https://doi.org/10.1080/17512433.2017.1292125","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17512433.2017.1292125","pdf_url":null,"source":{"id":"https://openalex.org/S102962966","display_name":"Expert Review of Clinical Pharmacology","issn_l":"1751-2433","issn":["1751-2433","1751-2441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2587682809"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044739438","display_name":"Elizabeth Mary Lamos","orcid":"https://orcid.org/0000-0001-8440-6371","observed_orcids":["https://orcid.org/0000-0001-8440-6371"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elizabeth Mary Lamos","raw_affiliation_strings":["Division of Endocrinology, Diabetes and Metabolism, University of Maryland School of Medicine , Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes and Metabolism, University of Maryland School of Medicine , Baltimore, MD, USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012245518","display_name":"Rana Malek","orcid":"https://orcid.org/0000-0002-8109-5050","observed_orcids":["https://orcid.org/0000-0002-8109-5050"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rana Malek","raw_affiliation_strings":["Division of Endocrinology, Diabetes and Metabolism, University of Maryland School of Medicine , Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes and Metabolism, University of Maryland School of Medicine , Baltimore, MD, USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080379883","display_name":"Stephen N. Davis","orcid":"https://orcid.org/0000-0001-8923-5209","observed_orcids":["https://orcid.org/0000-0001-8923-5209"]},"institutions":[{"id":"https://openalex.org/I1315496137","display_name":"University of Maryland Medical Center","ror":"https://ror.org/00sde4n60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315496137","https://openalex.org/I14285509"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Stephen N. Davis","raw_affiliation_strings":["Department of Medicine, University of Maryland Medical Center , Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Maryland Medical Center , Baltimore, MD, USA","institution_ids":["https://openalex.org/I1315496137"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5080379883"],"corresponding_institution_ids":["https://openalex.org/I1315496137"],"apc_list":null,"apc_paid":null,"fwci":0.7643,"has_fulltext":false,"cited_by_count":76,"citation_normalized_percentile":{"value":0.53089533,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"10","issue":"4","first_page":"401","last_page":"408"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polycystic-ovary-syndrome","display_name":"polycystic ovary syndrome","score":0.9909999966621399},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9610000252723694},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.8980000019073486},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":1.0},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8700000047683716},{"id":"https://openalex.org/keywords/hyperandrogenism","display_name":"hyperandrogenism","score":0.9240000247955322},{"id":"https://openalex.org/keywords/metformin-combination-therapy","display_name":"metformin combination therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/menstrual-frequency","display_name":"menstrual frequency","score":0.7300000190734863},{"id":"https://openalex.org/keywords/eating-habits","display_name":"dietary habits","score":0.8889999985694885},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7289999723434448},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.6850000023841858},{"id":"https://openalex.org/keywords/ovulation","display_name":"ovulation","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9060364365577698},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.896115779876709},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.6649833917617798},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6536512970924377},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.6290963888168335},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.5381214618682861},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5214656591415405},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.504726767539978},{"id":"https://openalex.org/C3018442814","wikidata":"https://www.wikidata.org/wiki/Q500816","display_name":"Polycystic ovary","level":4,"score":0.4759787619113922},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4693509042263031},{"id":"https://openalex.org/C2780186808","wikidata":"https://www.wikidata.org/wiki/Q10529545","display_name":"Hyperandrogenism","level":5,"score":0.46191906929016113},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.44556063413619995},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3015124797821045},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.26559150218963623},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.23719334602355957},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.22458362579345703},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21679958701133728},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.19750839471817017}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005247","descriptor_name":"Feeding Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011085","descriptor_name":"Polycystic Ovary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011085","descriptor_name":"Polycystic Ovary Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/17512433.2017.1292125","doi":"https://doi.org/10.1080/17512433.2017.1292125","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17512433.2017.1292125","pdf_url":null,"source":{"id":"https://openalex.org/S102962966","display_name":"Expert Review of Clinical Pharmacology","issn_l":"1751-2433","issn":["1751-2433","1751-2441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:28276778","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28276778","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W807162506","https://openalex.org/W1530949477","https://openalex.org/W1675810068","https://openalex.org/W1968073470","https://openalex.org/W1973102818","https://openalex.org/W1973442218","https://openalex.org/W1978635385","https://openalex.org/W1982510982","https://openalex.org/W1986902166","https://openalex.org/W1992338711","https://openalex.org/W2002575696","https://openalex.org/W2007816906","https://openalex.org/W2007842092","https://openalex.org/W2009155872","https://openalex.org/W2018636623","https://openalex.org/W2030579450","https://openalex.org/W2032360183","https://openalex.org/W2042639777","https://openalex.org/W2044967663","https://openalex.org/W2046541439","https://openalex.org/W2054614529","https://openalex.org/W2060979843","https://openalex.org/W2076412906","https://openalex.org/W2077815106","https://openalex.org/W2096126402","https://openalex.org/W2096887626","https://openalex.org/W2100211815","https://openalex.org/W2100306033","https://openalex.org/W2101316067","https://openalex.org/W2103297384","https://openalex.org/W2106378688","https://openalex.org/W2106824723","https://openalex.org/W2107080737","https://openalex.org/W2115094946","https://openalex.org/W2119823280","https://openalex.org/W2120973019","https://openalex.org/W2125769727","https://openalex.org/W2128660756","https://openalex.org/W2134431421","https://openalex.org/W2134745348","https://openalex.org/W2135749311","https://openalex.org/W2136847880","https://openalex.org/W2136864398","https://openalex.org/W2145360267","https://openalex.org/W2149183746","https://openalex.org/W2154632861","https://openalex.org/W2155715955","https://openalex.org/W2155744138","https://openalex.org/W2156480732","https://openalex.org/W2159152234","https://openalex.org/W2161330749","https://openalex.org/W2164180340","https://openalex.org/W2167170136","https://openalex.org/W2186218348","https://openalex.org/W2217459290","https://openalex.org/W2234331144","https://openalex.org/W2281463781","https://openalex.org/W2330618995","https://openalex.org/W2425644022","https://openalex.org/W2509560275","https://openalex.org/W2916747764","https://openalex.org/W4250005844"],"related_works":["https://openalex.org/W7126151822","https://openalex.org/W3161120012","https://openalex.org/W7113101400","https://openalex.org/W6908262728","https://openalex.org/W3032523510","https://openalex.org/W4366819379","https://openalex.org/W7111686929","https://openalex.org/W2566045659","https://openalex.org/W7129715656","https://openalex.org/W4292263170"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Polycystic":[1],"ovarian":[2],"syndrome":[3],"(PCOS)":[4],"affects":[5],"many":[6],"women":[7,103],"of":[8,31,63,91,98,175,177,182],"child-bearing":[9],"age":[10],"and":[11,17,41,109,134,185,191],"is":[12,24],"characterized":[13],"by":[14],"hyperandrogenism,":[15],"ovulatory":[16],"metabolic":[18],"dysfunction.":[19],"A":[20,124],"primary":[21],"treatment":[22,97],"goal":[23],"weight":[25,28,101,114],"reduction.":[26],"The":[27,88],"loss":[29],"effects":[30],"glucagon-like":[32,64],"peptide-1":[33,65],"receptor":[34,66],"agonists":[35],"(GLP-1RA),":[36],"previously":[37],"demonstrated":[38],"in":[39,69,95,102,113,120],"diabetic":[40],"obese":[42],"non-diabetic":[43],"patients,":[44],"offer":[45],"a":[46],"unique":[47],"opportunity":[48],"to":[49,55,83,166],"expand":[50],"the":[51,96,159,170,178,180,186],"medical":[52],"options":[53],"available":[54,89],"PCOS":[56,70,105],"patients.":[57],"Areas":[58],"covered:":[59],"Available":[60],"clinical":[61],"trials":[62],"agonist":[67],"therapy":[68,94],"were":[71,154],"reviewed.":[72],"Literature":[73],"was":[74],"searched":[75],"from":[76],"PubMed":[77],"using":[78],"appropriate":[79],"search":[80],"terms":[81],"up":[82],"November":[84],"2016.":[85],"Expert":[86],"commentary:":[87],"studies":[90,126],"GLP-1":[92],"RA":[93],"excess":[99],"body":[100],"with":[104,122,145,156],"demonstrate":[106],"that":[107,128],"exenatide":[108],"liraglutide":[110,146],"are":[111,150],"effective":[112],"reduction":[115],"either":[116],"as":[117],"monotherapy":[118],"or":[119],"combination":[121],"metformin.":[123],"few":[125],"showed":[127],"androgens":[129],"may":[130,137,142,168],"be":[131,138,143,169],"modestly":[132],"decreased":[133],"menstrual":[135],"frequency":[136],"increased.":[139],"Eating":[140],"behavior":[141],"improved":[144],"therapy.":[147],"Glucose":[148],"parameters":[149],"generally":[151],"improved.":[152],"GLP-1RAs":[153],"well-tolerated,":[155],"nausea":[157],"being":[158],"most":[160],"significant":[161],"adverse":[162],"side":[163],"effect.":[164],"Barriers":[165],"utilization":[167],"short":[171],"duration":[172],"studies,":[173],"lack":[174],"familiarity":[176],"medication,":[179],"route":[181],"administration":[183],"(injection)":[184],"variable":[187],"outcomes":[188],"on":[189],"ovulation":[190],"hyperandrogenism.":[192]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2587682809","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-02-17T00:00:00"}
